CDKN2A founder mutation in pancreatic ductal adenocarcinoma patients without cutaneous features of Familial Atypical Multiple Mole Melanoma (FAMMM) syndrome. This evidence concerns the gene CDKN2A and familial atypical multiple mole melanoma syndrome.